Epilepsy and comorbidity: infections and antimicrobials usage in relation to epilepsy management

被引:36
作者
Sander, JW
Perucca, E
机构
[1] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England
[2] Univ Pavia, Dept Internal Med & Therapeut, Clin Pharmacol Unit, I-27100 Pavia, Italy
来源
ACTA NEUROLOGICA SCANDINAVICA | 2003年 / 108卷
关键词
epilepsy; antimicrobials; neurocysticercosis; malaria; drug interactions;
D O I
10.1034/j.1600-0404.108.s180.3.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Infections are probably the most common preventable cause of epilepsy worldwide. There are concerns that endemic infections and infestations, such as malaria and neurocysticercosis, could be responsible for the increased incidence of epilepsy in the developing world. Cases of epilepsy associated with neurocysticercosis are also being seen increasingly in developed countries due to migration from, and travel to, endemic areas. When prescribing antimicrobial agents in patients with epilepsy a number of issues need to be considered, such as potential adverse effects on seizure control and interactions with concomitant antiepileptic drugs (AEDs). Some antimicrobial agents, including penicillins, cephalosporins, carbapenems, quinolones and antimalarials, can have proconvulsant activity and may precipitate seizures, even in patients who do not have epilepsy. Moreover, many antimicrobials increase or decrease the plasma levels of AEDs, whereas some AEDs may adversely affect the efficacy of antimicrobials.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 40 条
[1]  
Adamolekun B, 1993, West Afr J Med, V12, P231
[2]   Causes of epilepsy: Contributions of the Rochester epidemiology project [J].
Annegers, JF ;
Rocca, WA ;
Hauser, WA .
MAYO CLINIC PROCEEDINGS, 1996, 71 (06) :570-575
[3]   POPULATIONS AT RISK FOR PENICILLIN-INDUCED SEIZURES [J].
BARRONS, RW ;
MURRAY, KM ;
RICHEY, RM .
ANNALS OF PHARMACOTHERAPY, 1992, 26 (01) :26-29
[4]   Nervous system disorders - A global epidemic [J].
Bergen, DC ;
Silberberg, D .
ARCHIVES OF NEUROLOGY, 2002, 59 (07) :1194-1196
[5]  
BITTENCOURT PR, 1999, HDB CLIN NEUROLOGY E, V72, P145
[6]  
Burchard GD, 2001, NERVENARZT, V72, P460, DOI 10.1007/s001150050781
[7]   FLUCONAZOLE-INDUCED SYMPTOMATIC PHENYTOIN TOXICITY [J].
CADLE, RM ;
ZENON, GJ ;
RODRIGUEZBARRADAS, MC ;
HAMILL, RJ .
ANNALS OF PHARMACOTHERAPY, 1994, 28 (02) :191-195
[8]   Neurocysticercosis: an update [J].
Carpio, A .
LANCET INFECTIOUS DISEASES, 2002, 2 (12) :751-762
[9]  
DETURCK BJ, 1998, J ANTIMICROB CHEMOTH, V42, P430
[10]   Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin [J].
Ducharme, MP ;
Slaughter, RL ;
Warbasse, LH ;
Chandrasekar, PH ;
VandeVelde, V ;
Mannens, G ;
Edwards, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (06) :617-624